August 22, 2025 - 21:31

Nvidia and Marvell Technology, two prominent players in the AI semiconductor market, are set to release their earnings reports next week. As the demand for artificial intelligence continues to surge, both companies are in the spotlight, with investors keenly anticipating their financial performance.
Nvidia, renowned for its cutting-edge graphics processing units (GPUs), has been at the forefront of AI advancements, powering everything from data centers to gaming. The company’s innovative technologies have positioned it as a leader in the AI space, and analysts are eager to see how its latest earnings reflect this growth.
Similarly, Marvell Technology has been making strides in the semiconductor industry, particularly with its focus on infrastructure solutions for AI applications. Investors are looking to gauge how Marvell's strategies are translating into financial success as it navigates this rapidly evolving market.
With both companies poised to report, market watchers are bracing for potential impacts on stock prices and overall market sentiment in the tech sector.
October 28, 2026 - 23:36
CSX Works Through Tech Outage as Security Team Confirms No CyberattackCSX is working through a technology outage that began Tuesday, with the company`s security team confirming the disruption was not a cyberattack and that no data breach occurred, according to a...
October 28, 2026 - 06:35
The Human Side of Patient CRM Upgrades: Four Choices Tech Cannot SolveModernizing a patient relationship management system is often framed as a software problem, but the hardest parts are not technical. Jaymin Sutarwala of United Therapeutics argues that four key...
October 27, 2026 - 19:33
SPOOKY SPECTACULAR - GATEWAY HEADS-UP MAFIA 2026 GRAND FINALETwo days. More than 360 cars. Nearly $30,000 in payouts. One weekend that will not be forgotten anytime soon. Some races are good. Some are memorable. Then there are weekends that remind everyone...
October 27, 2026 - 00:50
Aptar Pharma Expands Pulmonary Delivery Capabilities with Pulmotree AcquisitionAptar Pharma, a division of AptarGroup Inc., has acquired Pulmotree, a life sciences company based in Munich, Germany. The move strengthens the company`s position in pulmonary drug delivery...